Even when we are not in the lab, Axxam is heavily involved in advancing research for neurological diseases, such as Alzheimer’s and Parkinson’s.
Indeed, our colleagues were kept busy last week at the BraYn Conference, Ilaria Prada on the BraYn steering committee and Fernanda Ricci as PerkinElmer, Inc.’s invited speaker in the neuroimaging session with a talk titled “Image-based phenotypic analysis as a tool for drug discovery at the cellular and sub-cellular level in neurological disease models”.
